The Cooper Companies Inc (BSP:C1OO34)
R$ 60.54 0 (0%) Market Cap: 120.57 Bil Enterprise Value: 135.18 Bil PE Ratio: 58.61 PB Ratio: 2.64 GF Score: 81/100

Cooper Companies Inc at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 16, 2022 / 07:20PM GMT
Release Date Price: R$48.55
Steven Michael Lichtman
Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst

Hi, everyone. I'm Steve Lichtman, medical devices analyst at Oppenheimer. Welcome to the 32nd Annual Oppenheimer Healthcare Conference.

Up next for us, I'm very happy to have the Cooper Companies. With us is Brian Andrews, Executive Vice President, CFO and Treasurer. We're going to do a fireside chat format. If you do have any questions, please key them in, and I will get them over to Brian. With that, Brian, thanks for joining us today.

Brian G. Andrews
The Cooper Companies, Inc. - Executive VP, CFO & Treasurer

Happy to be here, Steve. Thanks for having me.

Questions & Answers

Steven Michael Lichtman
Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst

So I thought we just sort of set the scene on the CDI side of your business. And wondering if you could lay out for investors where you think penetration sits on some of the key opportunities, including silicone hydrogel,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot